Creative Medical Technology Holdings Inc banner

Creative Medical Technology Holdings Inc
NASDAQ:CELZ

Watchlist Manager
Creative Medical Technology Holdings Inc Logo
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
Watchlist
Price: 1.84 USD -2.13% Market Closed
Market Cap: $6.4m

Creative Medical Technology Holdings Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Creative Medical Technology Holdings Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
Other Items
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Items
-$5.4B
CAGR 3-Years
N/A
CAGR 5-Years
32%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Other Items
-$4.2B
CAGR 3-Years
-35%
CAGR 5-Years
21%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Other Items
-$85m
CAGR 3-Years
74%
CAGR 5-Years
55%
CAGR 10-Years
33%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Items
-$507.8m
CAGR 3-Years
-63%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Items
$584.6m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Creative Medical Technology Holdings Inc
Glance View

Market Cap
6.4m USD
Industry
Biotechnology

Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company is headquartered in Phoenix, Arizona. The company went IPO on 2009-05-01. The firm conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction and female sexual dysfunction and female sexual dysfunction, respectively. The firm's products include CaverStem, FemCelz, StemSpine, Amniostem, ImmCelz and OvaStem. CaverStem utilizes a patient's own stem cells to treat erectile dysfunction (ED). FemCelz is used for the treatment and procedure for vaginal rejuvenation function.

CELZ Intrinsic Value
8.02 USD
Undervaluation 77%
Intrinsic Value
Price

See Also

What is Creative Medical Technology Holdings Inc's Other Items?
Other Items
0 USD

Based on the financial report for Sep 30, 2025, Creative Medical Technology Holdings Inc's Other Items amounts to 0 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett